Clinical Trials Sponsored by Critical Path Institute - Predictive Safety Testing Consortium

Total 2 results

Foundation for the National Institutes of Health
M.D. Anderson Cancer Center; Eli Lilly and Company; National Institute of Diabetes... and other collaborators

Unknown

A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers

Head and Neck Cancer

United States
Foundation for the National Institutes of Health
M.D. Anderson Cancer Center; Eli Lilly and Company; National Institute of Diabetes... and other collaborators

Unknown

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Cystic Fibrosis

United States

3

Subscribe